Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil

Detalhes bibliográficos
Autor(a) principal: Ossanai Schoenardie, Bruna
Data de Publicação: 2021
Outros Autores: Bazanella de Oliveira, Fabiana, Gollo Mazzotti, Nicolle, Palominos, Penélope Esther, Lubianca Kohem, Charles, Ferreira Cestari, Tania, Catucci Boza, Juliana
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/112863
Resumo: Introduction: several guidelines emphasize the advantages of multidisciplinary management of patients with psoriasis (PSO) or psoriatic arthritis (PSA). Early diagnosis of PSA relates to better outcomes in 5 years. However, early diagnosis of PSA remains a challenge. Methods: retrospective cohort of patients with previous or suspect diagnosis of PSO and/or PSA who were cared for in the combined dermatology and rheumatology clinic from January 2013 to January 2017.Results: among the 55 patients previously diagnosed with PSO, 30.9% (n=17) were diagnosed with PSA. Changes in medical therapy were made for 58.5% (n = 48) of patients, mainly due to poor cutaneous or articular disease control. Imunobiologicals were the most commonly initiated class of medicine, corresponding to 35.4% (n = 17) of changes in medical therapy. Methotrexate was the second most initiated medicine (18.7%; n = 9), or with changes in its dosage or route of administration (20.8%; n = 10), totaling 39.5% (n = 19) of changes in medical therapy. There was an increase in the proportions of patients undergoing systemic therapies (79.2%; n = 65).Conclusions: this study reenforces the importance of a multidisciplinary approach in the early diagnosis of PSA and demonstrates that a combined approach between dermatology and rheumatology is feasible in Brazil, with similar outcomes to those reported in international literature.
id UFRGS-20_8d6301763950e09080704f078f1a7a9d
oai_identifier_str oai:seer.ufrgs.br:article/112863
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasilpsoriasispsoriatic arthritismultidisciplinary researchearly diagnosis.Introduction: several guidelines emphasize the advantages of multidisciplinary management of patients with psoriasis (PSO) or psoriatic arthritis (PSA). Early diagnosis of PSA relates to better outcomes in 5 years. However, early diagnosis of PSA remains a challenge. Methods: retrospective cohort of patients with previous or suspect diagnosis of PSO and/or PSA who were cared for in the combined dermatology and rheumatology clinic from January 2013 to January 2017.Results: among the 55 patients previously diagnosed with PSO, 30.9% (n=17) were diagnosed with PSA. Changes in medical therapy were made for 58.5% (n = 48) of patients, mainly due to poor cutaneous or articular disease control. Imunobiologicals were the most commonly initiated class of medicine, corresponding to 35.4% (n = 17) of changes in medical therapy. Methotrexate was the second most initiated medicine (18.7%; n = 9), or with changes in its dosage or route of administration (20.8%; n = 10), totaling 39.5% (n = 19) of changes in medical therapy. There was an increase in the proportions of patients undergoing systemic therapies (79.2%; n = 65).Conclusions: this study reenforces the importance of a multidisciplinary approach in the early diagnosis of PSA and demonstrates that a combined approach between dermatology and rheumatology is feasible in Brazil, with similar outcomes to those reported in international literature.HCPA/FAMED/UFRGS2021-12-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/112863Clinical & Biomedical Research; Vol. 41 No. 4 (2021): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 41 n. 4 (2021): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/112863/pdfCopyright (c) 2021 Clinical and Biomedical Researchinfo:eu-repo/semantics/openAccessOssanai Schoenardie, BrunaBazanella de Oliveira, FabianaGollo Mazzotti, NicollePalominos, Penélope EstherLubianca Kohem, CharlesFerreira Cestari, TaniaCatucci Boza, Juliana2024-01-19T14:13:04Zoai:seer.ufrgs.br:article/112863Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:13:04Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
title Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
spellingShingle Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
Ossanai Schoenardie, Bruna
psoriasis
psoriatic arthritis
multidisciplinary research
early diagnosis.
title_short Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
title_full Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
title_fullStr Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
title_full_unstemmed Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
title_sort Ambulatório conjunto de Dermatologia e Reumatologia para tratamento de psoríase e artrite psoriásica: experiência de um hospital terciário no sul do Brasil
author Ossanai Schoenardie, Bruna
author_facet Ossanai Schoenardie, Bruna
Bazanella de Oliveira, Fabiana
Gollo Mazzotti, Nicolle
Palominos, Penélope Esther
Lubianca Kohem, Charles
Ferreira Cestari, Tania
Catucci Boza, Juliana
author_role author
author2 Bazanella de Oliveira, Fabiana
Gollo Mazzotti, Nicolle
Palominos, Penélope Esther
Lubianca Kohem, Charles
Ferreira Cestari, Tania
Catucci Boza, Juliana
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ossanai Schoenardie, Bruna
Bazanella de Oliveira, Fabiana
Gollo Mazzotti, Nicolle
Palominos, Penélope Esther
Lubianca Kohem, Charles
Ferreira Cestari, Tania
Catucci Boza, Juliana
dc.subject.por.fl_str_mv psoriasis
psoriatic arthritis
multidisciplinary research
early diagnosis.
topic psoriasis
psoriatic arthritis
multidisciplinary research
early diagnosis.
description Introduction: several guidelines emphasize the advantages of multidisciplinary management of patients with psoriasis (PSO) or psoriatic arthritis (PSA). Early diagnosis of PSA relates to better outcomes in 5 years. However, early diagnosis of PSA remains a challenge. Methods: retrospective cohort of patients with previous or suspect diagnosis of PSO and/or PSA who were cared for in the combined dermatology and rheumatology clinic from January 2013 to January 2017.Results: among the 55 patients previously diagnosed with PSO, 30.9% (n=17) were diagnosed with PSA. Changes in medical therapy were made for 58.5% (n = 48) of patients, mainly due to poor cutaneous or articular disease control. Imunobiologicals were the most commonly initiated class of medicine, corresponding to 35.4% (n = 17) of changes in medical therapy. Methotrexate was the second most initiated medicine (18.7%; n = 9), or with changes in its dosage or route of administration (20.8%; n = 10), totaling 39.5% (n = 19) of changes in medical therapy. There was an increase in the proportions of patients undergoing systemic therapies (79.2%; n = 65).Conclusions: this study reenforces the importance of a multidisciplinary approach in the early diagnosis of PSA and demonstrates that a combined approach between dermatology and rheumatology is feasible in Brazil, with similar outcomes to those reported in international literature.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-08
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/112863
url https://seer.ufrgs.br/index.php/hcpa/article/view/112863
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/112863/pdf
dc.rights.driver.fl_str_mv Copyright (c) 2021 Clinical and Biomedical Research
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Clinical and Biomedical Research
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 41 No. 4 (2021): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 41 n. 4 (2021): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767056261840896